Yamaga H - Search Results

1

Endoscopic classification of gastric varices.

Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Hashizume M, et al. Among authors: yamaga h. Gastrointest Endosc. 1990 May-Jun;36(3):276-80. doi: 10.1016/s0016-5107(90)71023-1. Gastrointest Endosc. 1990. PMID: 2365213

2

Over-tube is preferable to free-hand technique to avoid recurrence of varices after endoscopic injection sclerotherapy. Prospective randomized trial.

Kitano S, Yamaga H, Wada H, Hashizume M, Sugimachi K. Kitano S, et al. Among authors: yamaga h. Int Surg. 1992 Jul-Sep;77(3):137-40. Int Surg. 1992. PMID: 1399355 Clinical Trial.

3

Sclerotherapy vs. esophageal transection vs. distal splenorenal shunt for the clinical management of esophageal varices in patients with child class A and B liver function: a prospective randomized trial.

Kitano S, Iso Y, Hashizume M, Yamaga H, Koyanagi N, Wada H, Iwanaga T, Ohta M, Sugimachi K. Kitano S, et al. Among authors: yamaga h. Hepatology. 1992 Jan;15(1):63-8. doi: 10.1002/hep.1840150113. Hepatology. 1992. PMID: 1727801 Clinical Trial.

4

Endoscopic injection sclerotherapy for 1,000 patients with esophageal varices: a nine-year prospective study.

Hashizume M, Kitano S, Koyanagi N, Tanoue K, Ohta M, Wada H, Yamaga H, Higashi H, Iso Y, Iwanaga T, et al. Hashizume M, et al. Among authors: yamaga h. Hepatology. 1992 Jan;15(1):69-75. doi: 10.1002/hep.1840150114. Hepatology. 1992. PMID: 1727802

5

Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.

Higashi H, Kitano S, Hashizume M, Yamaga H, Wada H, Sugimachi K. Higashi H, et al. Among authors: yamaga h. Int Surg. 1991 Oct-Dec;76(4):214-7. Int Surg. 1991. PMID: 1778718

6

Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.

Kitano S, Wada H, Yamaga H, Hashizume M, Koyanagi N, Iwanaga T, Iso Y, Sugimachi K. Kitano S, et al. Among authors: yamaga h. J Gastroenterol Hepatol. 1991 Sep-Oct;6(5):476-80. doi: 10.1111/j.1440-1746.1991.tb00891.x. J Gastroenterol Hepatol. 1991. PMID: 1932669 Clinical Trial.

7

Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices.

Hashizume M, Yamaga H, Kitano S, Sugimachi K. Hashizume M, et al. Among authors: yamaga h. Hepatogastroenterology. 1990 Dec;37(6):565-8. Hepatogastroenterology. 1990. PMID: 2289769

8

Eradication of oesophageal varices recurring after portal non-decompressive surgery by injection sclerotherapy.

Hashizume M, Kitano S, Yamaga H, Wada H, Sugimachi K. Hashizume M, et al. Among authors: yamaga h. Br J Surg. 1990 Aug;77(8):940-3. doi: 10.1002/bjs.1800770832. Br J Surg. 1990. PMID: 2393824

9

Endoscopic injection sclerotherapy: variants of sclerotherapy technique.

Kitano S, Hashizume M, Yamaga H, Wada H, Sugimachi K. Kitano S, et al. Among authors: yamaga h. J Gastroenterol Hepatol. 1989;4 Suppl 1:171-2. J Gastroenterol Hepatol. 1989. PMID: 2519042 No abstract available.

10

Sclerotherapy superior to surgery for longer survival and less rebleeding in 103 cirrhotics with variceal bleeding.

Kitano S, Hashizume M, Yamaga H, Higashi H, Sugimachi K. Kitano S, et al. Among authors: yamaga h. Int Surg. 1989 Jul-Sep;74(3):162-6. Int Surg. 1989. PMID: 2606619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters